Multiple Myeloma
📧 Sign up to get email alerts when something new happens for Multiple Myeloma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2014-02-04Clinical Trial Update: A Trial of GS-9219 in Chronic Lymphocytic Leukemia (CLL), Non-Hodgkin's Lymphoma (NHL) or Multiple Myeloma (MM) [Phase 1, Phase 2]
Clinical trial GS-9219 in chronic lymphocytic leukemia, non-Hodgkin's lymphoma, and multiple myeloma (Phase 1/2) has been terminated.
-
CLINICAL_TRIALS trial_result · 2014-01-27Clinical Trial Update: A Phase 1 Dose-Escalation Study in Advanced Solid Tumors, Lymphomas or Multiple Myeloma [Phase 1]
A Phase 1 dose-escalation study sponsored by AVEO Pharmaceuticals in patients with advanced lymphomas and multiple myeloma has completed.
-
CLINICAL_TRIALS trial_result · 2014-01-22Clinical Trial Update: Lenalidomide and Dexamethasone With or Without Thalidomide in Treating Patients With Multiple Myeloma [Phase 3]
Phase 3 clinical trial evaluating lenalidomide and dexamethasone with or without thalidomide in patients with multiple myeloma (stages I–III…
-
CLINICAL_TRIALS trial_result · 2014-01-22Clinical Trial Update: Lenalidomide and Dexamethasone With or Without Thalidomide in Treating Patients With Multiple Myeloma [Phase 3]
Phase 3 trial evaluating lenalidomide and dexamethasone with or without thalidomide for multiple myeloma; results posted in 2014 with active…
-
CLINICAL_TRIALS trial_result · 2014-01-20Clinical Trial Update: Cyclophosphamide, VELCADE, DOXIL, and Dexamethasone, (CVDD) in Newly Diagnosed Patients With Multiple Myeloma (MM) [Phase 1, Phase 2]
This update reports results from a phase 1/2 study evaluating the CVDD combination (cyclophosphamide, bortezomib, liposomal doxorubicin, and…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2014-01-16Clinical Trial Update: Brostallicin in Treating Patients With Recurrent or Refractory Multiple Myeloma [Phase 1, Phase 2]
Phase 1/2 clinical trial of brostallicin for recurrent or refractory multiple myeloma and related plasma cell neoplasms has completed enroll…
-
CLINICAL_TRIALS trial_result · 2014-01-14Clinical Trial Update: VALEO: A Post Authorization Study, Designed to Learn More About the Safety and Effectiveness of the Use of Bortezomib in the Netherlands
A post-authorization study (VALEO) update evaluating the safety and effectiveness of bortezomib in the Netherlands has completed.
-
CLINICAL_TRIALS trial_result · 2014-01-10Clinical Trial Update: Stem Cell Transplant, Chemotherapy, and Biological Therapy in Treating Patients With High-Risk or Refractory Multiple Myeloma [Phase 1, Phase 2]
Clinical trial update on phase 1/2 testing of stem cell transplant, chemotherapy, and biological therapy in high-risk or refractory multiple…
-
CLINICAL_TRIALS research · 2014-01-10Clinical Trial Update: Bortezomib and Dexamethasone in Treating Patients With Multiple Myeloma That Has Relapsed or Has Not Responded to Treatment [Phase 2]
A Phase 2 clinical trial update evaluating bortezomib plus dexamethasone for relapsed or refractory multiple myeloma.
-
CLINICAL_TRIALS research · 2014-01-10Clinical Trial Update: Doxorubicin Hydrochloride Liposome, Melphalan, and Bortezomib in Treating Patients With Relapsed or Refractory Stage I, Stage II, or Stage III Multiple Myeloma [Phase 1, Phase 2]
This clinical trial update describes a Phase 1/Phase 2 study evaluating a combination of liposomal doxorubicin, melphalan, and bortezomib in…
-
CLINICAL_TRIALS trial_result · 2014-01-08Clinical Trial Update: Trisenox, Ascorbic Acid and Bortezomib in Patients With Relapsed/Refractory Multiple Myeloma [Phase 1]
Phase 1 trial evaluating arsenic trioxide (Trisenox), ascorbic acid, and bortezomib in relapsed/refractory multiple myeloma has been termina…
-
CLINICAL_TRIALS trial_result · 2014-01-06Clinical Trial Update: Combination of G-CSF, Bortezomib, Cyclophosphamide and Dexamethasone in Patients With Multiple Myeloma [Phase 2]
Phase 2 trial evaluating a combination of Granulocyte Colony-Stimulating Factor, Bortezomib, Cyclophosphamide, and Dexamethasone in patients…
-
CLINICAL_TRIALS trial_result · 2014-01-06Clinical Trial Update: Dexamethasone With or Without Oblimersen in Treating Patients With Relapsed or Refractory Multiple Myeloma [Phase 3]
Phase 3 trial evaluating dexamethasone with or without oblimersen for relapsed or refractory multiple myeloma has completed.
-
CLINICAL_TRIALS trial_result · 2014-01-06Clinical Trial Update: Prognostic Study of Markers of Angiogenesis and Coagulability in Patients With Monoclonal Gammopathy [NA]
Clinical trial update reporting completion of a prognostic study of angiogenesis and coagulability markers in patients with monoclonal gammo…
-
CLINICAL_TRIALS trial_result · 2014-01-06Clinical Trial Update: Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma or Other B-cell Cancers [Phase 2]
Phase 2 clinical trial update on peripheral stem cell transplantation for patients with multiple myeloma and other B-cell cancers, including…
-
CLINICAL_TRIALS research · 2014-01-06Clinical Trial Update: Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma [Phase 2]
This ClinicalTrials.gov entry reports a Phase 2 trial evaluating the combination of chemotherapy and peripheral stem cell transplantation in…
-
CLINICAL_TRIALS research · 2014-01-06Clinical Trial Update: Combination Chemotherapy Followed by Donor Bone Marrow Transplant or Peripheral Stem Cell Transplant in Treating Patients With Hematologic Cancer or Genetic Disorders [Phase 2]
Phase 2 clinical trial evaluating chemotherapy followed by donor bone marrow or peripheral stem cell transplantation in patients with hemato…
-
CLINICAL_TRIALS research · 2014-01-06Clinical Trial Update: Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer, Metastatic Kidney Cancer, or Aplastic Anemia [NA]
This entry discusses donor stem cell transplantation as a treatment option for patients with hematologic cancers, metastatic kidney cancer, …
-
CLINICAL_TRIALS research · 2013-12-31Clinical Trial Update: Comparable Investigation of One Fraction Radiotherapy and Multifraction Radiotherapy in Patients With Multiple Myeloma. [Phase 3]
An ongoing Phase 3 trial comparing one-fraction radiotherapy to multifraction radiotherapy in multiple myeloma; trial status is currently un…
-
CLINICAL_TRIALS trial_result · 2013-12-30Clinical Trial Update: Velcade Consolidation Bone Study [Phase 2]
Phase 2 Velcade (bortezomib) consolidation study for bone involvement in multiple myeloma has completed and results were posted.
-
CLINICAL_TRIALS research · 2013-12-30Clinical Trial Update: IMMUNOPHENOTYPE ROLE IN THE EVALUATION OF CLINICAL RESPONSE
A clinical trial exploring how immunophenotyping can be used to evaluate treatment response in multiple myeloma, including in the post-allog…
-
CLINICAL_TRIALS research · 2013-12-19Clinical Trial Update: Combination Chemotherapy With or Without Cyclophosphamide and Prednisone in Treating Older Patients With Multiple Myeloma [Phase 3]
An update on a Phase 3 trial evaluating combination chemotherapy with or without cyclophosphamide and prednisone in older patients with mult…
-
CLINICAL_TRIALS trial_result · 2013-12-19Clinical Trial Update: Combination Chemotherapy and Interferon Alfa With or Without Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Myeloma [Phase 3]
Phase 3 trial evaluating the addition of interferon alfa to chemotherapy, with or without bone marrow or peripheral stem cell transplantatio…
-
CLINICAL_TRIALS trial_result · 2013-12-18Clinical Trial Update: Doxorubicin Hydrochloride Liposome, Bortezomib, and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma [Phase 2]
A Phase 2 study evaluating liposomal doxorubicin, bortezomib, and dexamethasone in newly diagnosed multiple myeloma; the current trial statu…
-
CLINICAL_TRIALS trial_result · 2013-12-18Clinical Trial Update: Umbilical Cord Blood and Placental Blood Transplantation in Treating Patients With Hematologic Cancer or Aplastic Anemia [Phase 2]
Phase 2 clinical trial evaluating umbilical cord blood and placental blood transplantation for hematologic cancers or aplastic anemia. The s…